Haleon plc
HLN
Rangering i aksjer
#13649
Haleon plc operates as a global entity focused on developing, manufacturing,... Haleon plc operates as a global entity focused on developing, manufacturing, and marketing an array of consumer health products. Its operations extend across multiple continents, specifically North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers a comprehensive selection of items, encompassing therapeutic oral care, pain relief solutions, respiratory health aids, digestive wellness products, as well as vitamins, minerals, and other dietary supplements. Prominent brands within its extensive portfolio include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The firm, incorporated in 2021, was initially named DRVW 2022 plc before rebranding to Haleon plc in February 2022. Its corporate headquarters are located in Brentford, United Kingdom.
Aksjekurs
$5.12
Markedsverdi
$450.23M
Endring (1 dag)
-0.40%
Endring (1 år)
8.68%
Land
GB
Handel Haleon plc (HLN)
Kategori
Healthcare
Historikk for aksjesplitt for Haleon plc (HLN)
Aksjen Haleon plc (symbol: HLN) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 20, 2026.
Én HLN-aksje kjøpt før Oct 20, 2026 tilsvarer i dag 0 HLN-aksjer.
Den nyeste splittelsen skjedde Oct 20, 2026.
Én HLN-aksje kjøpt før Oct 20, 2026 tilsvarer i dag 0 HLN-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
